(Boursier.com) — The Cooper Companies, the American designer of medical equipment, specialist in ophthalmology, announced yesterday evening, for its fourth fiscal quarter, results in line with market expectations. Quarterly revenues were $927 million, up 9.3% year-over-year, while adjusted earnings per share were $3.47 versus $2.75 a year earlier. These figures come out very close to the average analyst estimates. For the full year, revenues represented $3.59 billion, an increase of 9% compared to last year and 11% at constant currencies. For fiscal 2024, revenue is expected to be between $3.809 billion and $3.877 billion, with organic growth of 6% to 8%. Adjusted diluted earnings per share are expected to be between $13.6 and $14.
©2023 Boursier.com